Iridex Corp (IRIX) is a publicly traded Healthcare sector company. As of September 10, 2026, IRIX trades at $0.69 with a market cap of $11.88M and a P/E ratio of 0.00. IRIX moved +0.00% today. Year to date, IRIX is -40.35%; over the trailing twelve months it is -50.00%. Its 52-week range spans $0.66 to $1.72. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces IRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for IRIX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.69 |
| Market Cap | $11.88M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.72 |
| 52-Week Low | $0.66 |
| Volume | 47.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover IRIX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.